Showing results (111-120 of 132) with videos related to
Sort By:
Pageof 14
Urology|July 1, 2014
Trends in disparate treatment of African American men with localized prostate cancer across National Comprehensive Cancer Network risk groupsBrandon A Mahal, Ayal A Aizer, David R Ziehr, et al.International Journal of Radiation Oncology, Biology, Physics|April 6, 2015
Hypofractionated versus standard radiation therapy with or without temozolomide for older glioblastoma patientsNils D Arvold, Shyam K Tanguturi, Ayal A Aizer, et al.Urologic Oncology|May 22, 2014
Getting back to equal: The influence of insurance status on racial disparities in the treatment of African American men with high-risk prostate cancerBrandon A Mahal, David R Ziehr, Ayal A Aizer, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 6, 2018
Impact of pemetrexed on intracranial disease control and radiation necrosis in patients with brain metastases from non-small cell lung cancer receiving stereotactic radiationDaniel N Cagney, Allison M Martin, Paul J Catalano, et al.Journal of Geriatric Oncology|May 28, 2014
Racial disparities in an aging population: the relationship between age and race in the management of African American men with high-risk prostate cancerBrandon A Mahal, David R Ziehr, Ayal A Aizer, et al.World Neurosurgery|October 13, 2019
Atypical Histopathological Features and the Risk of Treatment Failure in Nonmalignant Meningiomas: A Multi-Institutional AnalysisNayan Lamba, William L Hwang, Daniel W Kim, et al.Neuro-Oncology|September 2, 2015
A prognostic cytogenetic scoring system to guide the adjuvant management of patients with atypical meningiomaAyal A Aizer, Malak Abedalthagafi, Wenya Linda Bi, et al.World Neurosurgery|November 25, 2018
Neurosurgical Resection and Stereotactic Radiation Versus Stereotactic Radiation Alone in Patients with a Single or Solitary Brain MetastasisNayan Lamba, Daniel N Cagney, Rachel H Brigell, et al.Neuro-Oncology|June 4, 2014
Adjuvant radiation therapy, local recurrence, and the need for salvage therapy in atypical meningiomaAyal A Aizer, Nils D Arvold, Paul Catalano, et al.Oncotarget|January 23, 2015
Increased expression of the immune modulatory molecule PD-L1 (CD274) in anaplastic meningiomaZiming Du, Malak Abedalthagafi, Ayal A Aizer, et al.Pageof 14